July 15, 2020

Jubilee Metals Group Q&A: Expecting growth in earnings in H2 2020 (LON:JLP)

Jubilee Metals Group plc (LON:JLP) Chief Executive Officer Leon Coetzer caught up with DirectorsTalk for an exclusive interview to discuss the highlights from their operational update, production at the Sable..

Zeus Capital Analyst Q&A discussing the UK motor sector

The UK motor sector is the topic of conversation when Zeus Capital’s Head of Research Mike Allen caught up with DirectorsTalk for an exclusive interview. Q1: I wanted to tap..

City of London Investment Group “Business As Usual”

What’s new: On 13 July, at its EGM, shareholders approved City of London Investment Group plc (LON:CLIG) all share acquisition of Karpus Management Inc, “KMI”. On 14 July CLIG’s update..

Palace Capital Encouraging full-year results

The healthy liquidity position of Palace Capital plc (LON:PCA) takes risks down to a modest level, as does the overweight to regional offices and minimal shops. The Hudson Quarter mixed-development..

Ilika Q&A with Baden Hill: Full commercialisation and profitability (LON:IKA)

Ilika plc (LON:IKA) is the topic of conversation when Baden Hill’s Partner and Clean Tech Equity Specialist Dr Tom McColm caught up with DirectorsTalk for an exclusive interview. Q1: Ilika..

Vertu Motors “is well placed to emerge stronger from this downturn” says Zeus Capital

Vertu Motors plc (LON:VTU) has reported a strong performance for the month of June, following the reopening of all showrooms in England from 1 June and 12 Scottish showrooms reopening..

GlaxoSmithKline FDA advisory committee votes in favour of Belantamab mafodotin

GlaxoSmithKline plc (LON:GSK) has announced the US Food and Drug Administration Oncologic Drugs Advisory Committee voted 12-0 in favour of the demonstrated benefit of monotherapy treatment with belantamab mafodotin outweighing..

Burberry Group comparable sales down 45%

Burberry Group plc (LON:BRBY) has announced its first quarter trading update. “In Q1, sales were severely impacted by the drop in luxury demand from COVID-19 and we expect it will..

Severn Trent expecting up to £85 million negative impact to 2020/21 revenue

Severn Trent Plc (LON:SVT) has announced the following update for the period to 15 July 2020. We have remained focused on taking care of one of life’s essentials through the..

Allergy Therapeutics deliver strong 2020 performance despite COVID-19 challenge

Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, today provided a trading update for the year ended 30 June 2020 ahead of its Preliminary..

Capital Limited performs strongly in the first half of the year

Capital Limited (LON:CAPD), a leading mining services company focused on the African markets, has provided its trading update for the period 1 January to 30 June 2020. The Company will..

Open Orphan option to acquire CHIMagents Limited

Open Orphan plc (LON:ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials has..

Cambridge Cognition Holdings new virtual study with COVID-19 healthcare workers

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, is collaborating with 4YouandMe and The Center for International Emergency Medical Services to investigate the..

Search

Funds

July 15, 2020

Search

Funds

July 15, 2020

FTSE 100

Funds